In the November 2011 issue of the Journal of Diabetes in the Journal of Diabetes, the results of a study conducted by the Third Military Medical University, Newbridge Hospital and the American University of Arizona School of Pharmacy, etc., were first applied internationally at the international level. Orchids, cinnamon extracted elements of the intervention of diabetic nephropathy, obtained a significant effect. The results of this study, for the clinical treatment of diabetic nephropathy to find a new target.
The first author of the article, the Third Military Medical University, Xinqiao Hospital, Department of Endocrinology, Dr. Zheng Hongting, deputy director of the United States and Arizona University School of Medicine Donna Zhang research group, through the mouse in vivo experiments and in vitro cell model observation found that from the food broccoli and Chinese medicine The two substances extracted from cinnamon and cinnamaldehyde can weaken the symptoms of glucose metabolism and improve the glucose metabolism disorder and renal injury caused by diabetes, so as to explore a new path for the treatment of clinical diabetic nephropathy. The research work has been funded by the National Natural Science Foundation of China.
It is understood that the Journal of the American Diabetes Association journal "Diabetes" magazine also distributed by the internationally renowned diabetes research scholar, Australia Baker IDI heart diabetes research center Judy B.Haan professor wrote a special review.
Professor Haan pointed out in this review, diabetic nephropathy is a common complication of diabetes, diabetes is also one of the main causes of death. In the United States, diabetic nephropathy accounts for the first term of end-stage renal failure, about 35% to 38%. Although the current clinical dependence on enhanced metabolic control and other interventions to try to delay its progress, but with the ruthless attenuation of renal function, many patients still inevitably into the stage of renal failure, this situation led to the urgency of the new treatment need. And Dr. Zheng Hongting's research is expected to provide a new way for the treatment of diabetic nephropathy.
Beijing In China